561 results on '"de Ferranti, Sarah"'
Search Results
2. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
3. Enhanced Safety and Efficiency of Ambulatory Cardiology Admissions: A Quality Improvement Initiative
4. Genetic testing for familial hypercholesterolemia
5. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN
6. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children
7. Abstract 19033: Increased Prevalence of Gaps in Care for Patients With Congenital Heart Disease Are Associated With Social Determinants of Health Including Childhood Opportunity Index
8. Abstract 18937: High Prevalence of Pediatric Hypertension is Associated With Social Determinants of Health Including Childhood Opportunity Index
9. Isometric Exercise Increases the Diameter of the Ascending Aorta in Youth with Bicuspid Aortic Valves
10. Disproportionate Negative Career Impact of the COVID-19 Pandemic on Female Pediatric Cardiologists in the Northeast United States
11. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis
12. Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices
13. Dyslipidemia Among Adults With Congenital Heart Disease
14. Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease
15. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050--Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
16. Helping young women go red: Harnessing the power of personal and digital information to prevent heart disease
17. Abstract 10745: Return to Play After Covid-19 Infection: Cardiac Imaging Findings in Youth
18. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes
19. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry
20. Cardiovascular health decline in adolescent girls in the NGHS cohort, 1987–1997
21. Young Women's Perceptions of Heart Disease Risk
22. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
23. Food Insecurity and Ideal Cardiovascular Health Risk Factors Among US Adolescents.
24. Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition From Childhood to Adulthood
25. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
26. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children
27. Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population
28. Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids
29. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease
30. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events
31. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
32. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
33. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
34. Special Considerations for Healthy Lifestyle Promotion Across the Life Span in Clinical Settings: A Science Advisory From the American Heart Association
35. Social Determinants of Health Including Child Opportunity Index Leading to Gaps in Care for Patients With Significant Congenital Heart Disease.
36. Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders.
37. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel
38. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children
39. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease
40. Stakeholders’ Perspectives on Stakeholder-engaged Research (SER) : Strategies to Operationalize Patient-centered Outcomes Research Principles for SER
41. Abstract 194: Age, Gender, Race/ethnicity, and Income-related Patterns in Ideal Cardiovascular Health
42. Abstract 12598: Stress Testing During Long-term Follow-up After Kawasaki Disease
43. Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials
44. Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice
45. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians
46. Kawasaki disease and immunisation: A systematic review
47. Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices
48. The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart Association
49. 52 - Evaluating murmurs, chest pain, and syncope
50. 44 - Preventive cardiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.